Products Categories
CAS No.: | 147526-32-7 |
---|---|
Name: | Pitavastatin calcium |
Article Data: | 38 |
Molecular Structure: | |
Formula: | (C25H23FNO4)2.Ca |
Molecular Weight: | 880.999 |
Synonyms: | Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt;6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, calcium salt (2:1), (S-(R*,S*-(E)))-;Pitavastatin hemicalcium;UNII-IYD54XEG3W;Livalo;CCRIS 8652; |
EINECS: | 807-641-2 |
Boiling Point: | 692 °C at 760 mmHg |
Flash Point: | 372.3 °C |
Appearance: | white to off-white powder |
Safety: | 24/25 |
PSA: | 186.96000 |
LogP: | 6.36680 |
methyl (3R,5S,6E)-7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoate
pitavastatin
Conditions | Yield |
---|---|
With sodium hydroxide In methanol at 20℃; for 0.5h; | 100% |
With water; sodium hydroxide In methanol at 20℃; for 2h; Product distribution / selectivity; |
pitavastatin calcium salt
pitavastatin
Conditions | Yield |
---|---|
With hydrogenchloride In water; ethyl acetate at 25 - 35℃; | 95.9% |
With hydrogenchloride In dichloromethane; water at 0 - 25℃; for 0.833333h; pH=3; | |
With hydrogenchloride In water; ethyl acetate pH=4; | 3.7 g |
With hydrogenchloride In dichloromethane; water |
(4R,6S)-(E)-{6-[2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-vinyl]-2,2-dimethyl-1,3-dioxan-4-yl}acetic acid tert-butyl ester
pitavastatin
Conditions | Yield |
---|---|
Stage #1: (4R,6S)-(E)-{6-[2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-vinyl]-2,2-dimethyl-1,3-dioxan-4-yl}acetic acid tert-butyl ester With trifluoroacetic acid In acetonitrile at 30 - 35℃; Stage #2: With caesium carbonate In acetonitrile at 35 - 40℃; | 94% |
Multi-step reaction with 3 steps 1.1: water; oxalic acid / methanol / 6 h / 35 °C 1.2: 2.75 h / 10 - 30 °C / pH 7 2.1: sodium hydroxide; water / methanol / 1.67 h / 0 °C 2.2: 0.67 h / 25 °C 3.1: hydrogenchloride / dichloromethane; water / 0.83 h / 0 - 25 °C / pH 3 View Scheme | |
Multi-step reaction with 4 steps 1.1: water; oxalic acid / methanol / 6 h / 35 °C 1.2: 2.75 h / 10 - 30 °C / pH 7 2.1: sodium hydroxide; water / acetonitrile / 1.5 h / 30 °C 2.2: 0.25 h / 0 °C / pH 4 2.3: 0.5 h / 0 °C 3.1: sodium hydroxide / water / 0.75 h / 30 °C 3.2: 0.75 h / 35 °C 4.1: hydrogenchloride / dichloromethane; water / 0.83 h / 0 - 25 °C / pH 3 View Scheme | |
Multi-step reaction with 2 steps 1: hydrogenchloride / acetonitrile; water / 2 h / 13 °C 2: sodium hydroxide / water / 2 h / 10 °C / Large scale View Scheme |
(E)-(3R,5S)-7-[2-cyclopropyl-4-(4-fluoro-phenyl)-quinolin-3-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl ester
pitavastatin
Conditions | Yield |
---|---|
With ethanol; sodium hydroxide In water at 20℃; for 3h; | 87.4% |
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester
pitavastatin
Conditions | Yield |
---|---|
With sodium hydroxide In water at 10℃; for 2h; Large scale; | 83.9% |
Stage #1: (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester With hydrogenchloride; water In methanol at 25℃; for 2.16667h; Stage #2: With hydrogenchloride In dichloromethane at 0 - 25℃; for 0.916667h; pH=3; | |
Multi-step reaction with 2 steps 1.1: sodium hydroxide; water / methanol / 1.67 h / 0 °C 1.2: 0.67 h / 25 °C 2.1: hydrogenchloride / dichloromethane; water / 0.83 h / 0 - 25 °C / pH 3 View Scheme | |
Multi-step reaction with 3 steps 1.1: sodium hydroxide; water / acetonitrile / 1.5 h / 30 °C 1.2: 0.25 h / 0 °C / pH 4 1.3: 0.5 h / 0 °C 2.1: sodium hydroxide / water / 0.75 h / 30 °C 2.2: 0.75 h / 35 °C 3.1: hydrogenchloride / dichloromethane; water / 0.83 h / 0 - 25 °C / pH 3 View Scheme |
pitavastatin
Conditions | Yield |
---|---|
With sodium hydroxide In methanol for 12h; Ambient temperature; |
pitavastatin
Conditions | Yield |
---|---|
Stage #1: (±)-E-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-6-heptenoic acid ethyl ester With sodium hydroxide Hydrolysis; Stage #2: With (+)-1-phenylethylamine resolution; |
pitavastatin
Conditions | Yield |
---|---|
Stage #1: (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-[(1S)-1-phenylethyl]hept-6-enamide With sodium hydroxide In ethanol at 50 - 55℃; for 26h; Stage #2: With hydrogenchloride In ethyl acetate Further stages.; |
2-cyclopropyl-4-(4-fluorophenyl)-3-(hydroxymethyl)quinoline
pitavastatin
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1.1: DMSO; P2O5; Et3N 2.1: NaOH; (n-octyl)3MeNCl / toluene; H2O 3.1: DIBAH 4.1: NaH; n-BuLi 5.1: NaBH4; Et2BOMe / -78 °C 6.1: aq. NaOH 6.2: (+)-α-methylbenzylamine View Scheme | |
Multi-step reaction with 4 steps 1.1: phosphorus tribromide / dichloromethane / 1.5 h / 25 °C 1.2: 1 h / 75 °C 2.1: potassium carbonate / dimethyl sulfoxide / 7 h / 75 °C 3.1: water; oxalic acid / methanol / 6 h / 35 °C 3.2: 2.75 h / 10 - 30 °C / pH 7 4.1: hydrogenchloride; water / methanol / 2.17 h / 25 °C 4.2: 0.92 h / 0 - 25 °C / pH 3 View Scheme | |
Multi-step reaction with 5 steps 1.1: phosphorus tribromide / dichloromethane / 1.5 h / 25 °C 1.2: 1 h / 75 °C 2.1: potassium carbonate / dimethyl sulfoxide / 7 h / 75 °C 3.1: water; oxalic acid / methanol / 6 h / 35 °C 3.2: 2.75 h / 10 - 30 °C / pH 7 4.1: sodium hydroxide; water / methanol / 1.67 h / 0 °C 4.2: 0.67 h / 25 °C 5.1: hydrogenchloride / dichloromethane; water / 0.83 h / 0 - 25 °C / pH 3 View Scheme | |
Multi-step reaction with 6 steps 1.1: phosphorus tribromide / dichloromethane / 1.5 h / 25 °C 1.2: 1 h / 75 °C 2.1: potassium carbonate / dimethyl sulfoxide / 7 h / 75 °C 3.1: water; oxalic acid / methanol / 6 h / 35 °C 3.2: 2.75 h / 10 - 30 °C / pH 7 4.1: sodium hydroxide; water / acetonitrile / 1.5 h / 30 °C 4.2: 0.25 h / 0 °C / pH 4 4.3: 0.5 h / 0 °C 5.1: sodium hydroxide / water / 0.75 h / 30 °C 5.2: 0.75 h / 35 °C 6.1: hydrogenchloride / dichloromethane; water / 0.83 h / 0 - 25 °C / pH 3 View Scheme | |
Multi-step reaction with 5 steps 1: thionyl chloride / toluene; dichloromethane / 15 °C 2: toluene / 12 h / Reflux; Large scale 3: potassium carbonate / dimethyl sulfoxide / 3 h / 30 - 50 °C / Large scale 4: hydrogenchloride / acetonitrile; water / 2 h / 13 °C 5: sodium hydroxide / water / 2 h / 10 °C / Large scale View Scheme |
2-cyclopropyl-4-(4-fluorophenyl)-3-formylquinoline
pitavastatin
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1.1: NaOH; (n-octyl)3MeNCl / toluene; H2O 2.1: DIBAH 3.1: NaH; n-BuLi 4.1: NaBH4; Et2BOMe / -78 °C 5.1: aq. NaOH 5.2: (+)-α-methylbenzylamine View Scheme | |
Multi-step reaction with 3 steps 1.1: sodium t-butanolate / 1-methyl-pyrrolidin-2-one; 2-methyltetrahydrofuran; tetrahydrofuran / -60 - 22 °C 2.1: hydrogenchloride / acetonitrile; water / 1.5 h / 45 °C 2.2: 1.5 h 3.1: hydrogenchloride / water; ethyl acetate / pH 4 View Scheme | |
Multi-step reaction with 4 steps 1.1: sodium t-butanolate / 1-methyl-pyrrolidin-2-one; 2-methyltetrahydrofuran; tetrahydrofuran / -60 - 22 °C 2.1: hydrogenchloride / acetonitrile; water / 2.5 h / 45 °C 2.2: 1.5 h / 10 °C 3.1: sodium hydroxide / water / pH 12.3 3.2: 1.25 h / pH 9.7 4.1: hydrogenchloride / water; ethyl acetate / pH 4 View Scheme |
What can I do for you?
Get Best Price
Molecular structure of Pitavastatin calcium (CAS NO.147526-32-7) is:
Product Name: Pitavastatin calcium
CAS Registry Number: 147526-32-7
IUPAC Name: calcium(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
Molecular Weight: 880.983646 [g/mol]
Molecular Formula: (C25H23FNO4)2.Ca
H-Bond Donor: 4
H-Bond Acceptor: 12
Flash Point: 372.3 °C
Enthalpy of Vaporization: 106.48 kJ/mol
Boiling Point: 692 °C at 760 mmHg
Vapour Pressure: 4.21E-20 mmHg at 25°C
Product Categories: Active Pharmaceutical Ingredients;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;chemical
Pitavastatin calcium (CAS NO.147526-32-7) can be used as a competitive inhibitor of HMG-CoA reductase.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | oral | 100mg/kg (100mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA GASTROINTESTINAL: NAUSEA OR VOMITING | Oyo Yakuri. Pharmacometrics. Vol. 56, Pg. 67, 1998. |
rat | LDLo | oral | 500mg/kg (500mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Oyo Yakuri. Pharmacometrics. Vol. 56, Pg. 67, 1998. |
Pitavastatin calcium , its cas register number is 147526-32-7. It also can be called Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt ; NK 104 ; CCRIS 8652 ; Livalo ; Pitavastatin hemicalcium ; UNII-IYD54XEG3W ; 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, calcium salt (2:1), (S-(R*,S*-(E)))- .It is a white to off-white powder.